Morphologic Spectrum of HPV-associated Sinonasal Carcinomas
Authors:
- 5 August 2024
- journal article
- research article
- Published by Springer Nature in Head and Neck Pathology
- Vol. 18 (1) , 1-11
Abstract
Background High-risk human papillomavirus (HR-HPV) infection has been increasingly recognized as a risk factor for sinonasal tract carcinomas. However the prevalence and prognostic significance of HPV-associated sinonasal carcinomas is not well known due to limited studies and inconsistency in HPV testing modalities in literatures. Morphologically, HPV-associated sinonasal carcinomas encompass a diverse group of tumors. HPV-associated sinonasal adenocarcinoma has not been reported. The purpose of this study was to determine the prevalence, morphologic spectrum and prognostic implication of HPV-associated sinonasal carcinomas. Methods This cohort included 153 sinonasal carcinomas. Tissue microarrays were constructed. P16 immunohistochemistry and HR-HPV E6/7 in-situ Hybridization (ISH) were performed. Carcinomas were deemed HPV-associated based on a positive ISH testing. Clinicopathologic data was collected. Results 28/153 (18%) sinonasal carcinomas were HPV-associated. HPV-associated carcinomas consisted of 26 (93%) squamous cell carcinomas and variants, 1 (3.5%) HPV-related multiphenotypic sinonasal carcinoma and 1 (3.5%) adenocarcinoma. The HPV-associated adenocarcinoma closely resembled HPV-associated endocervical adenocarcinoma morphologically. HPV-associated carcinomas occurred in 8 (29%) women and 20 (71%) men with a median age of 66 years old. HPV-associated carcinomas were predominantly located at nasal cavity. A trend toward improved overall survival and progression free survival in HPV-associated carcinomas patients was observed, yet without statistical significance. Conclusion Our study identifies a novel HPV-associated sinonasal adenocarcinoma subtype, highlights the broad morphologic spectrum of HPV-associated sinonasal carcinomas, and supports routine p16 testing during pathology practice regardless of tumor subtype followed by a confirmatory HR-HPV testing. This practice is critical for studying the clinical behavior of HPV-associated sinonasal carcinomas.Keywords
Funding Information
- Wisconsin Head & Neck SPORE grant (P50 DE026787), P50 DE026787), P50 DE026787), P50 DE026787), P50 DE026787))
This publication has 44 references indexed in Scilit:
- High‐risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinomaCancer, 2023
- P16 and human papillomavirus in sinonasal squamous cell carcinomaHead & Neck, 2020
- Human papillomavirus and survival of patients with sinonasal squamous cell carcinomaCancer, 2019
- Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall SurvivalJAMA Otolaryngology–Head & Neck Surgery, 2018
- Significance of human papillomavirus positivity in sinonasal squamous cell carcinomaInternational Forum of Allergy & Rhinology, 2017
- The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesisVirchows Archiv, 2015
- Incidence and survival in patients with sinonasal cancer: A historical analysis of population‐based dataHead & Neck, 2011
- Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a prospective clinical experienceCancer, 2010
- Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcomeCancer, 2009
- Detection of human papillomavirus DNA in carcinomas of the nasal cavities and paranasal sinuses by polymerase chain reactionCancer, 1992